BD announced the launch of the BD U-500 Insulin Syringe, the first insulin syringe designed for patients with diabetes taking Humulin R U-500 insulin (regular insulin [human, rDNA origin]; Eli Lilly).

New York, April 04, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Insulin Syringes Market Size, Share & Industry Trends Analysis Report By Disease, By Syringe ...

Nipro Medical Corporation has initiated a nationwide recall of GlucoPro insulin syringes because the defective products may contain needles that can detach from the syringe. If the needle becomes ...

ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

WASHINGTON — A Huntsville, Ala., company is recalling about 250 million Accusure insulin syringes it has distributed nationwide since January 2002 because the products’ needles could detach from the ...

October 29, 2009 — Accusure insulin syringes (Qualitest Pharmaceuticals, Inc) distributed nationwide from January 2002 through October 2009 are being voluntary recalled because of the possibility of ...

PROVIDENCE, R.I. (WPRI) ─ Certain lots of insulin syringes are being recalled because the graduation markings are skewed, which could cause the user to administer the wrong dose, according to the Food ...

Qualitest Pharmaceuticals is recalling two lots of Accusure insulin syringes because the products' needles can detach from the syringes. When the needle becomes detached from the syringe during use, ...

Insulin is generally administered either by the patient himself or by some member of his family, a neighbor, a practical nurse or a registered nurse. Only occasionally is it given by the physician.